Pinnbrook Capital Management LP Invests $1.50 Million in Revvity Inc. $RVTY

Pinnbrook Capital Management LP bought a new position in Revvity Inc. (NYSE:RVTY) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 13,500 shares of the company’s stock, valued at approximately $1,502,000.

Several other large investors have also made changes to their positions in RVTY. AQR Capital Management LLC lifted its stake in shares of Revvity by 5.2% in the 1st quarter. AQR Capital Management LLC now owns 8,449 shares of the company’s stock valued at $883,000 after purchasing an additional 420 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Revvity by 6.7% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,776 shares of the company’s stock worth $1,246,000 after purchasing an additional 744 shares during the period. Millennium Management LLC increased its position in Revvity by 102.0% during the 1st quarter. Millennium Management LLC now owns 69,401 shares of the company’s stock worth $7,343,000 after purchasing an additional 35,048 shares in the last quarter. Goldman Sachs Group Inc. grew its stake in Revvity by 45.5% during the first quarter. Goldman Sachs Group Inc. now owns 607,104 shares of the company’s stock worth $64,232,000 after buying an additional 189,871 shares during the period. Finally, Focus Partners Wealth grew its stake in Revvity by 13.0% during the first quarter. Focus Partners Wealth now owns 7,028 shares of the company’s stock worth $744,000 after buying an additional 811 shares during the period. 86.65% of the stock is owned by hedge funds and other institutional investors.

Revvity Stock Up 0.6%

Shares of NYSE:RVTY opened at $124.88 on Friday. The company has a market capitalization of $13.94 billion, a price-to-earnings ratio of 59.47, a price-to-earnings-growth ratio of 2.27 and a beta of 1.07. The company has a 50 day moving average of $111.45 and a two-hundred day moving average of $100.37. Revvity Inc. has a 52-week low of $81.22 and a 52-week high of $124.97. The company has a quick ratio of 1.50, a current ratio of 1.80 and a debt-to-equity ratio of 0.36.

Revvity (NYSE:RVTY) last posted its earnings results on Tuesday, August 4th. The company reported $1.41 EPS for the quarter, topping analysts’ consensus estimates of $1.21 by $0.20. Revvity had a net margin of 8.16% and a return on equity of 8.34%. The business had revenue of $729.69 million for the quarter, compared to analysts’ expectations of $702.96 million. During the same period in the previous year, the company posted $1.18 earnings per share. The business’s revenue for the quarter was down 1.3% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. As a group, analysts forecast that Revvity Inc. will post 5.36 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Investors of record on Friday, October 23rd will be paid a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $0.28 annualized dividend and a yield of 0.2%. Revvity’s payout ratio is 13.33%.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. Barclays raised their target price on shares of Revvity from $95.00 to $105.00 and gave the company an “equal weight” rating in a research note on Thursday, May 7th. Wolfe Research began coverage on shares of Revvity in a research report on Tuesday, June 2nd. They set a “peer perform” rating for the company. Stifel Nicolaus lowered their price target on Revvity from $110.00 to $100.00 and set a “hold” rating for the company in a report on Wednesday, May 6th. Robert W. Baird set a $117.00 price objective on Revvity in a research report on Wednesday, May 6th. Finally, Evercore restated an “outperform” rating on shares of Revvity in a research note on Wednesday, August 5th. Three analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $108.36.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.